MedTrace Logo

Minimal Invasive Surgery for Gastric Subepithelial Tumor

NCT05452265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 194

Last updated 2022-07-11

No results posted yet for this study

Summary

The investigators conducted a retrospective study of those patients with gastric SETs receiving ER or LR at the operative theater in the single institution from January 2013 to December 2021. Medical records were retrospectively reviewed to define patient/tumor characteristics and operative outcomes.

Conditions

  • Gastric Subepithelial Tumor

Interventions

PROCEDURE

Endoscopic resection

Complete resection of gastric SETs was recommended if the tumor size was \>2 cm, presence of malignant features, or if the patient was symptomatic, declined periodical surveillance, and preferred to undergo diagnostic and therapeutic resection.

Sponsors & Collaborators

  • Changhua Christian Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05452265 on ClinicalTrials.gov